Upgrade to SI Premium - Free Trial

CME Group (CME) PT Raised to $344 at Barclays

April 8, 2026 3:51 AM
Barclays analyst Benjamin Budish raised the price target on CME Group (NASDAQ: CME) to $344.00 (from $312.00) while maintaining a Equalweight rating.

Categories

Analyst PT Change